Deficient or aberrant FGF21 is associated with NAFLD/NASH, and elevated FGF21 serum levels correlate with hepatic fat content in mice and humans (reviewed in [37]). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.